Navigation Links
ACC Concerned Over Reporting of Biomonitoring Results
Date:10/23/2007

inform us about how the chemical was introduced, how long it has been there, or whether it poses any health risk what so ever. It would be erroneous to suggest that just because effects can be observed in toxicity studies at high doses of a chemical, that the same effects would occur at much, much lower doses.

The chemical industry recognizes that environmental health issues represent a legitimate concern, and we both recognize and act on our responsibility to help preserve a healthy environment, not only for our own children, but also for future generations. This is a fundamental responsibility we take seriously. ACC members meet this responsibility through compliance with a network of regulatory safeguards including many federal and state laws and through voluntary programs, such as Responsible Care(R), the HPV Challenge and the Voluntary Children's Chemical Evaluation Program Pilot. (VCCEP). Annually, our industry invests over $26 billion on research and innovation, $14 billion on complying with the dozens of federal, and hundreds of state regulations that govern the products, processes and distribution of the products of chemistry, and above that ACC members have invested over $120 million over the past five years in research to evaluate health and environmental impacts of chemicals -- much of which relates to the interpretation of biomonitoring data.

To Learn More About Biomonitoring and Responsible Reporting of Results:

Centers for Disease Control and Prevention

http://www.cdc.gov/exposurereport/

National Academy of Sciences

http://www.nap.edu/catalog.php?record_id=11700

BiomonitoringInfo.Org http://www.biomonitoringinfo.org

http://www.americanchemistr
'/>"/>

SOURCE American Chemistry Council
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Sept. 4, 2015  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the Wells Fargo Securities 2015 Healthcare Conference in ... September 10 th at 2:30 p.m. Eastern Time. To ... discussion, please visit the Investors section of the Company,s Web ... for 14 days after the event.  Orexigen Contact: ...
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: ... Brent Saunders , CEO and President of Allergan, will ... the Morgan Stanley Global Healthcare Conference 2015 in ... http://photos.prnewswire.com/prnh/20150612/222796LOGO The presentation will take place ... at the Grand Hyatt New York, 109 East 42nd Street, ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ) has announced ... Ibandronate Market, 2010-2019" report to their offering. ... name of Bondronat in Germany and ... approved by the FDA to come into the market as ... Boniva. However, since drug makers later developed more convenient dose, ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3Investigation Report on China's Sodium Ibandronate Market 2010-2019 2
(Date:9/4/2015)... ... ... The Schmidt National Law Group filed an Essure® lawsuit against Bayer and ... Group, a leading firm in mass-tort litigation, has filed a lawsuit in the federal ... other Bayer affiliates for injuries alleged to have been caused by her Essure® contraceptive ...
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia ... is launching a charity effort to provide for the family of Grace, a ... enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – the inability to ...
(Date:9/4/2015)... Monroe, NC (PRWEB) , ... September 04, 2015 ... ... Girl’s Night out to benefit Core Compassion Project. Core Compassion Project is ... a specialized program to reduce the side effects of cancer treatments and recover ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... that CEREC technology is now available at CitiDent. CEREC is a newer method ... addition to saving time for patients by eliminating the need for multiple appointments, ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way to ... The patent-pending K Med Cups provide a quick and simple way to brew a hot ... flu or cough. As a result, they enhance comfort and health. The invention features a ...
Breaking Medicine News(10 mins):Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: ... provider of pharmacy benefits management technology and services, ... maintenance and professional services agreements, and a software ... The agreements provide Prime with software licensing, software ...
... Chia Seed Flour is the buzz when it comes to ... Seed Flour is made from the tiny chia seeds. The ... It is the most nutritious grain available today. Now, thanks ... Flour is once again available for dinner tables everywhere. It ...
... Industry-leading and renowned laparoscopic bariatric surgeon Dr. ... selected by medical device manufacturers to introduce a ... County Region.Dr. Smith continues to lead the way ... as SILS (Single Incision Laparoscopic Surgery), at Specialty ...
... SAO PAULO and PHILADELPHIA, May 20 moksha8, Inc. ... with Roche to commercialize an additional portfolio of products ... , , moksha8 will commercialize products in ... The product portfolio consists of well-known brands including Rivotril(R), ...
... Area high schoolers take to the stage at the House of ... most creative seat belt messagesCLEVELAND, May 20 Local teens had ... -- at the House of Blues at noon on Tuesday, May ... Lose It High School Seat Belt Challenge, sponsored by Kohl,s, ...
... May 20 A three-minute video gave Midwesterners all the ... when Kansas City Public Television aired "Imagine KC." The video ... for the benefit of all. The project is the latest ... KC-based studio which has successfully marketed over $6 Billion in ...
Cached Medicine News:Health News:SXC Health Solutions announces agreements for pharmacy technology services with Prime Therapeutics LLC 2Health News:SXC Health Solutions announces agreements for pharmacy technology services with Prime Therapeutics LLC 3Health News:SXC Health Solutions announces agreements for pharmacy technology services with Prime Therapeutics LLC 4Health News:Nuchia Foods' Gluten-Free Chia Seed Flour Is a Tasty, Low-Fat Alternative Flour 2Health News:Nuchia Foods' Gluten-Free Chia Seed Flour Is a Tasty, Low-Fat Alternative Flour 3Health News:Dr. Adam Smith Chosen to Help Introduce No-Scar Surgical Weight-Loss Innovations 2Health News:moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico 2Health News:Rainbow Babies & Children's Hospital's Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens 2Health News:Rainbow Babies & Children's Hospital's Use It or Lose It High School Seat Belt Challenge Brings Out the Creativity in Cuyahoga County Teens 3Health News:Arnold Imaging Video Generates Public Enthusiasm for Light Rail 2
... VERSASTEP™ Plus Short Instrument ... , ,The VERSASTEP™ Plus ... Working Length is a unique ... applications in laparoscopic procedures. It ...
... Trocar consists of a blunt obturator connected ... assembly. , ,The valve body assembly ... to prevent gas leakage when instruments are ... Trocar includes built-in converters to allow insertion ...
... Premium One-Step™ single-use system device is comprised ... device components for creating each access port ... , Step™ insufflation and access needle, ... separately. , Step™ radially expandable sleeve, 100 ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
Medicine Products: